Showing 588 Results
Interested in Comparative Effectiveness Policy? Apply for Our Post-Doctoral Fellowship
In recent years, public and private funding for comparative effectiveness research (CER) has dramatically increased, with the intention of providing useful information to help patients and providers…
Partnerships in Real-World Evidence Explored at PCMA Annual Meeting
Why are partnerships on real-world evidence among payers and pharmaceutical companies becoming more prevalent? That’s what National Pharmaceutical Council President Dan Leonard asked participants…
Webinar: Role of Pharmaceuticals in the ACO Environment
The National Pharmaceutical Council invites you to participate in an Advisor Live webinar, "The role of pharmaceuticals in the accountable care organization (ACO) environment." Advisor Live is a…
CER Communications: Helping Patients Make Informed Decisions
Any guidelines for communicating comparative effectiveness research (CER) must focus on positioning patients to make informed decisions about their health care, according to Art Caplan, PhD, Director…
Two Perspectives on Academic Detailing and CER Communication
With hundreds of millions of dollars being invested in comparative effectiveness research (CER), most health care stakeholders acknowledge that there needs to be a focus on putting findings into…
A Look at the CER Communications Landscape
The digital landscape has opened the door for a variety of stakeholders to share comparative effectiveness research (CER) online, but it’s not always easy to gauge the quality of the information…
Ensuring a Free Flow of CER Information
By Dan Leonard, President, National Pharmaceutical Council
The Good, the Bad, and the Different: Deciphering Heterogeneity
Heterogeneity is the variation in, or diversity of, participants, interventions, and outcomes within or between studies and patients. Every day, pharmacy and medical managers in managed care…
Leading Researchers Outline Principles for Planning & Conduct of CER
A new set of principles developed by a group of leading researchers could help to ensure more consistency in how comparative effectiveness research (CER) is planned and conducted.
The Role of Pharmaceuticals in the ACO Environment
Mark your calendars for October 16 from 2 pm-3pm ET and plan to participate in a special webinar about the role of pharmaceuticals in the accountable care organization (ACO) environment.
Public Comment Period Begins for PCORI's Draft Methodology Report
The Patient-Centered Outcomes Research Institute (PCORI) today announced that it will begin accepting public comments on its draft methodology report. This document, which outlines a set of 60 best…
NPC Research Highlighted at Academy Health's Annual Research Meeting
NPC’s collaborative research, “What is the Real World Impact of Comparative Effectiveness Research (CER) Findings on Utilization?” will be highlighted at Academy Health’s Annual Research Meeting on…
NPC's Chief Science Officer to Speak at DIA 2012 Annual Meeting Executive Session
NPC Chief Science Officer Dr. Robert Dubois will speak during the “DIA 2012 Executive Session: Pioneering Partnerships” at the Drug Information Association’s Annual Meeting on June 26 at 10 a.m…
Principles for the Conduct of Comparative Effectiveness Research
Several researchers and stakeholders are developing a set of principles about what constitutes good comparative effectiveness research (CER) principles for oncology, according to an article in today…
Journal of Comparative Effectiveness Research Invites Submissions
The Journal of Comparative Effectiveness Research, a bimonthly, peer-reviewed journal, is now inviting submissions. The Journal's scope includes studies of comparative effectiveness research yielding…
Will CER Stimulate or Depress Innovation in Healthcare?
With the establishment of the Patient-Centered Outcomes Research Institute in the United States and growth in comparative effectiveness research (CER) worldwide, health care stakeholders are…
Challenges with CER Uptake in Clinical Practice
The goal of comparative effectiveness research (CER) is to improve health care decision making by patients and providers. Given the expected influx of CER in coming years via public and private…
Individual Treatment Effects: From Research to Action
During the next few years, a substantial number of comparative effectiveness research (CER) studies will examine a treatment’s effect on the average population, which may not apply to everyone. That…
Research Methods 101: Will Individual Treatment Effects Be Considered?
In the last post of this month’s series on research methods, we wanted to touch upon an important aspect of comparative effectiveness research: what happens when a treatment works well for the…
A Translation Table for Patient-Centered Comparative Effectiveness Research
This series of papers, published today in the Journal of Comparative Effectiveness Research, explore the challenges and opportunities with selecting appropriate research methods, soliciting…